The Florida Senate

110.109  Productivity improvement and personnel audits of executive branch agencies.--The department shall be responsible for conducting personnel audits of all executive branch agencies, except the State University System, to provide as follows:

(1)  In order to provide for the improvement of productivity and human resources management, the department shall have the authority to conduct agency personnel administration and management reviews to assist agencies in identifying areas of recommended improvement. Such reviews shall be conducted in cooperation with the internal auditor of the employing agency so as to ascertain the operational necessity and effectiveness of agency personnel programs and human resource management. A copy of any such reviews made by the department shall be submitted to the Legislature and the Auditor General.

(2)  It shall be the duty of the department to audit the personnel programs of the state agencies on a continuing and regular basis to ensure the agencies' compliance with state laws and regulations. A copy of such study made by the department shall be submitted to the Governor, the President of the Senate, the Speaker of the House of Representatives, and the Auditor General.

(3)  At the conclusion of the audit, the Secretary of Management Services or the secretary's designated representative shall discuss the audit with the official whose office is subject to audit and submit to him or her a list of his or her adverse findings which may be included in the audit report. If the official is not available for receipt of the list of adverse audit findings, clearly designated as such, then delivery thereof is presumed to be made when it is delivered to the official's office. The official shall submit to the Secretary of Management Services or the secretary's designated representative, within 30 days after the receipt of the list of findings, his or her written statement of explanation or rebuttal concerning all of the findings, including therein corrective action to be taken to preclude a recurrence of adverse findings.

History.--s. 20, ch. 79-190; s. 4, ch. 88-290; s. 1, ch. 91-431; s. 11, ch. 92-279; s. 55, ch. 92-326; s. 659, ch. 95-147.